University of Texas, Southwestern
University of Texas, Southwestern
Dallas, Texas, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL | B-cell acute lymphoblastic leukemia, B-cell neoplasm, Body Weight, Burkitt lymphoma, DNA Virus Infections, Epstein-Barr virus infection, Hemic and Lymphatic Diseases, Herpesviridae infectious disease, Infections, Leukemia, B-Cell, Neoplasms by Histologic Type, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Pediatric Obesity, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Signs and Symptoms, Tumor Virus Infections, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, nutritional disorder, obesity disorder, overnutrition, viral infectious disease | Recruiting | Phase 2 | 2026-08-19 | NCT05082519 | |
| Danon Disease Natural History Study | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Danon disease, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, X-linked disease, cardiomyopathy, cardiovascular disorder, disorder of glycogen metabolism, heart disorder, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, intellectual disability, metabolic disease, nervous system disorder | Recruiting | Not stated | 2026-07-28 | NCT06214507 | |
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma | Hemic and Lymphatic Diseases, Leukemia, Lymphocytic, Acute, L1, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 / Phase 2 | 2025-06-17 | NCT03817320 | |
| Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies | B-cell neoplasm, CD4+/CD56+ hematodermic neoplasm, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Neoplasms by Histologic Type, Neoplasms by Site, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Skin and Connective Tissue Diseases, T-cell non-Hodgkin lymphoma, acute biphenotypic leukemia, acute lymphoblastic leukemia, acute myeloid leukemia, acute undifferentiated leukemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, malignant histiocytosis, mixed phenotype acute leukemia, myelodysplastic syndrome, neoplasm, skin disorder, skin neoplasm | Recruiting | Phase 1 | 2024-12-06 | NCT05476770 |